Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-08-18
2011-10-25
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S352000
Reexamination Certificate
active
08044102
ABSTRACT:
Novel formulations combining a non-steroidal anti-inflammatory drug (NSAID) such as flunixin, with a fluorinated chloramphenicol or thiamphenicol derivative antibiotic such as florfenicol are disclosed. Methods for using such formulations in the treatment and prevention of infectious diseases of bovines and swine, including bovine respiratory disease and swine respiratory disease, are also disclosed.
REFERENCES:
patent: 4733011 (1988-03-01), Riefling et al.
patent: 5082863 (1992-01-01), Apelian et al.
patent: 5242910 (1993-09-01), Damanj
patent: 6054434 (2000-04-01), Kropp et al.
patent: 6423298 (2002-07-01), McNamara et al.
patent: 6787568 (2004-09-01), Mihalik
patent: 6790867 (2004-09-01), Kohan et al.
patent: 2004/0242546 (2004-12-01), Freehauf et al.
patent: 0 980 248 (2000-02-01), None
patent: WO 02/41899 (2002-05-01), None
Veterinary Pharmaceuticals and Biologicals, VPB 10 Edition, 1997/1998.
D. A. Y. Adawa, et al., “Clinical Trial of Long-Acting Oxytetracycline and Piroxicam in the Treatment of Canine Ehrlichiosis”, The Veterinary Quarterly, vol. 14. No. 3, Aug. 1992, pp. 118-120.
I.E. Selman, et. al., “Evaluation of the Efficacy of Flunixin Meglumine Using Four Different Experimentally Induced Bovine Respiratory Disorders”, International Symposium on Nonsteroidal Antiinflammatory Agents, Orlando, Florida, Jan. 1986, pp. 23-32.
I. E. Selman, et al., “The effects of Flunixin meglumine and oxytetracycline therapy, alone and in combination, in calves with experimentally-induced pneumonic pasteurellosis”, Fourteenth World Congress on Diseases of Cattle, World Association for Buiatrics, vol. 1, (Aug. 1986), pp. 606-610.
J. Deleforge, et al., “A field evaluation of the efficacy of tolfenamic acid and oxytetracycline in the treatment of bovine respiratory disease”, J. Vet. Pharmacol. Therap. 17 (1994), pp. 43-47.
Order fromSchering-Plough Ltd.v.Norbrook Labs, Ltd., HC 05 C00186 (CH. 2005), dated Nov. 25, 2005.
Expert Report of Professor Graham Buckton, submitted in conjunction with theSchering-Plough Ltd.v.Norbrook Labs Ltd., HC 05 C00186 (CH. 2005), proceeding.
Expert Report of Professor Jonathan Elliott, submitted in conjunction with theSchering-Plough Ltd.v.Norbrook Labs Ltd. HC 05 C00186 (CH. 2005), proceeding.
Index to Bundle 2, Statements of Case Orders, fromSchering-Plough Ltd.v.Norbrook Labs, Ltd, HC 05 C00186 (Ch. 2005).
Judgment approved for handing down fromSchering-Plough Ltdv.Norbrook Labs Ltd., HC 05 C00186 (CH. 2005), dated Nov. 18, 2005.
Copending claims of U.S. Appl. No. 10/857,695, [AH06056US01], pp. 2-5.
Freehauf Keith A
Huq Abu
Kohan Raul E.
Simmons Robert D.
Varma Kanwal J.
Intervet Inc.
Jean-Louis Samira
Padmanabhan Sreeni
LandOfFree
Compositions and method for treating infection in cattle and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and method for treating infection in cattle and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and method for treating infection in cattle and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4301619